Ryan Udell is the co-leader of the firm's Life Sciences Industry Group. He advises companies throughout the corporate life cycle—and across industry sectors—in mergers, acquisitions, sales, licensing, and capital raising. He helps emerging growth companies to secure financing and represents angel and venture capital investors in debt and equity transactions. Ryan is particularly known for his work in the technology industry.
With a deep knowledge of business and an extensive professional network, Ryan helps connect companies to funding sources, identify challenges before they become problems, and develop practical, customized solutions that meet their business goals. He handles matters for clients in the biotechnology and medical technology, cannabis, health care, information technology, pharmaceuticals, life sciences, and software fields.
- Led the team that represented Boathouse Capital in its investment in Finch, a Salt Lake City-based paid digital media automation platform for marketing organizations
- Represented Progress Physical Therapy in a multimillion dollar membership interest purchase agreement with Ivy Rehab, a network of more than 175 outpatient physical and occupational therapy clinics across 10 states
- Represented a life sciences revenue analytics software company as it merged with a life sciences commercial data and analytics company, creating an updated data and analytics solutions organization
Association for Corporate Growth
Life Sciences Collaborative
Pennsylvania Alliance for Capital and Technologies
Pharmaceutical Consulting Consortium International
Recognition & Accomplishments
Law & Politics, “Rising Star—Pennsylvania,” 2005-2008, 2010, 2011
SmartCEO, “Philadelphia’s Legal Elite,” 2010, 2011
Board Memberships & Community Service
Temple University James E. Beasley of School of Law (J.D., magna cum laude, 1996)
Emory University (B.A. 1993)